Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Fransje E Reesink"'
Autor:
Guilherme D Kolinger, David Vállez García, Antoon T M Willemsen, Fransje E Reesink, Bauke M de Jong, Rudi A J O Dierckx, Peter P De Deyn, Ronald Boellaard
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248122 (2021)
Quantification of amyloid load with positron emission tomography can be useful to assess Alzheimer's Disease in-vivo. However, quantification can be affected by the image processing methodology applied. This study's goal was to address how amyloid qu
Externí odkaz:
https://doaj.org/article/19713534b05a4f1f8019a18914968653
Autor:
Joyce Vrijsen, Els LM Maeckelberghe, Peter Paul De Deyn, Andrea F de Winter, Fransje E Reesink, Richard C Oude Voshaar
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Introduction Descendants of patients with dementia have a higher risk to develop dementia. This study aims to investigate the uptake and effectiveness of an online tailor-made lifestyle programme for dementia risk reduction (DRR) among middle-aged de
Externí odkaz:
https://doaj.org/article/29a51f2bea0a45089a9c88cd8f70167b
Autor:
Débora E Peretti, David Vállez García, Fransje E Reesink, Tim van der Goot, Peter P De Deyn, Bauke M de Jong, Rudi A J O Dierckx, Ronald Boellaard
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0211000 (2019)
In Alzheimer's Disease (AD) dual-tracer positron emission tomography (PET) studies with 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) and 11C-labelled Pittsburgh Compound B (PIB) are used to assess metabolism and cerebral amyloid-β deposition, respectively
Externí odkaz:
https://doaj.org/article/cc27b1122dbe45f6b224dfe94668021f
Autor:
Débora E Peretti, David Vállez García, Fransje E Reesink, Tim van der Goot, Peter P De Deyn, Bauke M de Jong, Rudi A J O Dierckx, Ronald Boellaard
Publikováno v:
PLoS ONE, Vol 14, Iss 3, p e0214187 (2019)
[This corrects the article DOI: 10.1371/journal.pone.0211000.].
Externí odkaz:
https://doaj.org/article/307b8b016c0c4d109947c3384e203fdb
Autor:
Marie R. Vermeiren, Joost Somsen, Gert Luurtsema, Fransje E. Reesink, Nicolaas A. Verwey, Liesbeth Hempenius, Nelleke Tolboom, Geert Jan Biessels, J. Matthijs Biesbroek, Meike W. Vernooij, Sophie E. M. Veldhuijzen van Zanten, Harro Seelaar, Emma M. Coomans, Charlotte E. Teunissen, Afina W. Lemstra, Argonde C. van Harten, Leonie N. C. Visser, Wiesje M. van der Flier, Elsmarieke van de Giessen, Rik Ossenkoppele
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background Tau-PET is a diagnostic tool with high sensitivity and specificity for discriminating Alzheimer’s disease (AD) dementia from other neurodegenerative disorders in well-controlled research environments. The role of tau-PET in real
Externí odkaz:
https://doaj.org/article/d3a59bc2cf6d4922a76611eb0bd5f947
Autor:
Peter Paul De Deyn, Ulrich L. M. Eisel, Petrus J.W. Naudé, Inez H.G.B. Ramakers, Fransje E. Reesink, Wiesje M. van der Flier, Lize C. Jiskoot, Huiberdina L Koek, Jurgen A H R Claassen
Publikováno v:
Naudé, P J W, Ramakers, I H G B, van der Flier, W M, Jiskoot, L C, Reesink, F E, Claassen, J A H R, Koek, H L, Eisel, U L M & de Deyn, P P 2021, ' Serum and cerebrospinal fluid Neutrophil gelatinase-associated lipocalin (NGAL) levels as biomarkers for the conversion from mild cognitive impairment to Alzheimer's disease dementia ', Neurobiology of Aging, vol. 107, pp. 1-10 . https://doi.org/10.1016/j.neurobiolaging.2021.07.001
Neurobiology of Aging, 107, 1-10. Elsevier Inc.
Neurobiology of aging
Neurobiology of Aging, 107, pp. 1-10
Neurobiology of Aging, 107, 1-10
Neurobiology of Aging, 107, 1-10. ELSEVIER SCIENCE INC
Neurobiology of Aging, 107, 1-10. Elsevier Science
Neurobiology of Aging, 107, 1-10. Elsevier Inc.
Neurobiology of aging
Neurobiology of Aging, 107, pp. 1-10
Neurobiology of Aging, 107, 1-10
Neurobiology of Aging, 107, 1-10. ELSEVIER SCIENCE INC
Neurobiology of Aging, 107, 1-10. Elsevier Science
Neutrophil gelatinase-associated lipocalin (NGAL) is an acute phase protein that has been reported as a potential marker for pre-dementia stages of Alzheimer's disease (AD). Longitudinal studies for its association with the conversion of mild cogniti
Autor:
Nena Lejko, Stefanie Enriquez‐Geppert, Fransje E Reesink, Peter Paul De Deyn, Jacoba M Spikman, André Aleman
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Shankar Tumati, Esther M. Opmeer, Jan-Bernard C. Marsman, Sander Martens, Fransje E. Reesink, Peter P. De Deyn, André Aleman
Publikováno v:
Frontiers in Aging Neuroscience, Vol 10 (2018)
Apathy is a common symptom in patients with amnestic mild cognitive impairment (aMCI) and is associated with an increased risk of progression to Alzheimer’s disease (AD). The neural substrates underlying apathy in aMCI may involve multiple brain re
Externí odkaz:
https://doaj.org/article/5c02a1a0ac3a42b68ba4c6e6a9426f5d
Autor:
Rick van Veen, Sanne K. Meles, Remco J. Renken, Fransje E. Reesink, Wolfgang H. Oertel, Annette Janzen, Gert-Jan de Vries, Klaus L. Leenders, Michael Biehl
Publikováno v:
Computer Methods and Programs in Biomedicine, 225:107042. ELSEVIER IRELAND LTD
Background and Objectives 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) combined with principal component analysis (PCA) has been applied to identify disease-related brain patterns in neurodegenerative disorders such as Parkinson’
Autor:
Débora E. Peretti, David Vállez García, Remco J. Renken, Fransje E. Reesink, Janine Doorduin, Bauke M. de Jong, Peter P. De Deyn, Rudi A. J. O. Dierckx, Ronald Boellaard
Publikováno v:
Peretti, D B E, Vállez García, D, Renken, R J, Reesink, F E, Doorduin, J, de Jong, B M, de Deyn, P P, Dierckx, R A J O & Boellaard, R 2022, ' Alzheimer’s disease pattern derived from relative cerebral flow as an alternative for the metabolic pattern using SSM/PCA ', EJNMMI Research, vol. 12, no. 1, 37 . https://doi.org/10.1186/s13550-022-00909-8
EJNMMI Research, 12(1):37. SpringerOpen
EJNMMI Research, 12(1):37. Springer Berlin
EJNMMI research
EJNMMI Research, 12(1):37. SpringerOpen
EJNMMI Research, 12(1):37. Springer Berlin
EJNMMI research
Background 2-Deoxy-2-[18F]fluoroglucose (FDG) PET is an important tool for the identification of Alzheimer’s disease (AD) patients through the characteristic neurodegeneration pattern that these patients present. Regional cerebral blood flow (rCBF)